People
Fred Aswad
Fred Aswad is a venture partner named by GT Healthcare Capital Partners. His primary manager biography describes biotechnology research and drug-discovery work at Bayer, including immuno-oncology programmes, followed by a senior biology position at IDEAYA Biosciences focused on small-molecule therapies and synthetic lethality. It identifies an immunology PhD from the University of Southern California. Apeiron Therapeutics’ current team page identifies him as chief scientific officer and supplies a genuine name-bound headshot. That page contains an unrelated sentence referring to Jim and a Duke degree; the inconsistent sentence is excluded. His outside scientific career does not establish personal investment allocations.
Roles
Venture Partner